Reported Earlier, BriaCell Therapeutics Prices $30M Public Offering Of 5,366,726 Units At $5.59 Per Unit To Fund Working Capital And Advance Immunotherapy Programs

Each Warrant is immediately exercisable, will entitle the holder to purchase one common share at an exercise price of $6.93 per share and will expire five years from the date of issuance.